Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Vascular Neurology

Building Your Care Team: Specialists and Support

At a Glance

Cerebral proliferative angiopathy is best evaluated by a multidisciplinary neurovascular team familiar with its rare, diffuse vessel pattern. Bring complete MRI, CT, and angiography images, ask how CPA differs from an AVM, and seek a second opinion before major treatment when safe.

Because Cerebral Proliferative Angiopathy (CPA) is so rare, your care should not be managed by a single doctor, but by a multidisciplinary cerebrovascular team [1][2]. This team works together to ensure that the unique biology of your condition—where healthy brain is mixed with abnormal vessels—is respected in every decision [3][4].

The ideal setting for CPA care is a major academic medical center or a high-volume neurovascular program. These centers have the specialized imaging and expertise necessary to distinguish CPA from standard AVMs, a distinction that is critical for your safety [3][5].

The Core Care Team

A well-rounded team for CPA should include specialists from at least these four areas:

  • Vascular Neurologist: Often the “quarterback” of your team, this doctor specializes in the medical management of brain blood flow. They handle seizure control, headache management, and monitoring for signs of low blood flow (ischemia) [6][7]. (Note: Epilepsy specialists or headache specialists may also lead these areas.)
  • Interventional Neuroradiologist: This specialist performs the Digital Subtraction Angiography (DSA) used to map your vessels. They are also the ones who can perform “targeted” treatments, such as coiling a specific aneurysm within the CPA network [8][9].
  • Cerebrovascular Neurosurgeon: While traditional surgery is rarely used for CPA, you need a surgeon who understands “indirect revascularization” (like EDAS) and can evaluate whether your brain needs more blood supply [1][10].
  • Diagnostic Neuroradiologist: These doctors specialize in reading complex brain scans. Their role is to look for the “hallmarks” of CPA, such as the absence of a compact nidus and the presence of healthy brain tissue intermingled with the vessels [4][11].

For children and adolescents, the team must also include pediatric neurovascular specialists who understand how these conditions interact with a growing brain [12][1].

Vetting Your Care Team

When you meet with a potential team, remember that you are interviewing them as much as they are evaluating you. Because CPA is often mistaken for a standard AVM, you must ensure they understand the difference [5][3].

Key signs of a qualified team:

  • They focus on symptom management and hemodynamics (how blood moves), not just “fixing” the appearance of the scan [10][13].
  • They emphasize the risks of aggressive treatment and why active surveillance is often a proactive, evidence-based choice [14][15].
  • They can explain why they wouldn’t use traditional AVM treatments like diffuse radiation or major surgery in your case [3][16].

Your “First Visit” Toolkit

To get the most out of a consultation, especially if you are seeking a second opinion, you must bring your actual imaging data, not just the written reports.

  • Imaging Discs (DICOM files): Bring or transfer all relevant prior studies, including every MRI, CT, and DSA you have ever had. The specialists need to see the “raw” images to look for subtle signs of blood flow changes or transdural supply [17][4].
  • Full Medical Reports: Bring the written interpretations of those scans, but remember that the team will perform their own independent review of the images [4].
  • Symptom Journal: Keep a detailed log of your headaches (frequency and type), any seizure activity, or episodes of temporary weakness (TIAs). This helps the team correlate your “symptoms” with what they see on the “scans” [6][10].
  • Medication List: Include any blood thinners, blood pressure medications, or seizure drugs you are currently taking [7].

If a center suggests an aggressive treatment for the entire CPA network (like total removal or full-field radiation), it is highly recommended to seek a second opinion (when clinically safe to do so without delaying emergency care) at a center that specializes in rare vascular anomalies before proceeding [3][5].

Common questions in this guide

Which specialists should be involved in cerebral proliferative angiopathy care?
A CPA team commonly includes a vascular neurologist, interventional neuroradiologist, cerebrovascular neurosurgeon, and diagnostic neuroradiologist. Children and adolescents may also need pediatric neurovascular specialists. One clinician may coordinate care, but important decisions should be reviewed across the team.
How do specialists distinguish CPA from a diffuse AVM?
Specialists review MRI, CT, and cerebral angiography for a pattern in which healthy brain tissue is mixed with abnormal vessels and there is no compact nidus. A multidisciplinary review helps prevent CPA from being managed like a typical arteriovenous malformation.
What should I bring to my first CPA specialist appointment?
Bring the original DICOM files for all prior MRI, CT, and digital subtraction angiography studies, along with the written reports. Also bring a symptom journal covering headaches, seizures, or temporary weakness and a complete medication list, including blood thinners and seizure medicines.
When should I seek a second opinion for CPA?
A second opinion at a high-volume center specializing in rare vascular anomalies is especially reasonable if a team recommends major surgery or full-field radiation for the entire CPA network. Seek it when clinically safe, and do not delay emergency care.
What treatments might be considered for cerebral proliferative angiopathy?
Management may include active surveillance, symptom control, or a focused procedure for a specific problem such as an aneurysm. If blood-flow markers decline, a cerebrovascular surgeon may assess indirect revascularization such as EDAS; treating the entire vascular network is not automatically appropriate.
How can I tell whether a medical center has experience with CPA?
Ask how many CPA cases the center has managed, whether a multidisciplinary neurovascular board reviews imaging together, and how clinicians distinguish CPA from a diffuse AVM. The team should explain blood flow, the risks of aggressive treatment, and why surveillance or a targeted intervention fits your situation.

Get notified when new evidence is published on Cerebral proliferative angiopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Cerebral proliferative angiopathy in pediatric patients: case-based review with an illustrative case.

    Moskalik AD, Mo J, Sawyerr M, et al.

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2026; (42(1)):62 doi:10.1007/s00381-026-07129-8.

    PMID: 41652190
  2. 2

    Antiepileptic Treatment Strategy in Vascular Malformations.

    Giakoumettis D, Margetis K, Stranjalis G, et al.

    Current pharmaceutical design 2017; (23(42)):6454-6463 doi:10.2174/1381612823666171027142718.

    PMID: 29076420
  3. 3

    Cerebral Proliferative Angiopathy in a Child, Five Years after an Intraventricular Hemorrhage and Negative Catheter Angiography.

    Singfer U, Baert E, Defreyne L

    Journal of the Belgian Society of Radiology 2023; (107(1)):55 doi:10.5334/jbsr.3247.

    PMID: 37546522
  4. 4

    Cerebral Proliferative Angiopathy: Imaging Spectrum and Diagnostic Insights.

    Rai P, Chan VEY, Lakhani DA, et al.

    AJNR. American journal of neuroradiology 2026; (47(7)):1776-1784 doi:10.3174/ajnr.A9122.

    PMID: 41326231
  5. 5

    Volume staged stereotactic radiosurgery and endovascular embolization in the treatment of cerebral proliferative angiopathy: lessons learned.

    Brake A, Fry L, Chatley KS, et al.

    British journal of neurosurgery 2024; (38(5)):1047-1051 doi:10.1080/02688697.2021.2013437.

    PMID: 34894924
  6. 6

    Presentation and management of cerebral proliferative angiopathy: a systematic review and meta-analysis on treatment outcomes.

    Palavani LB, Mitre LP, Almeida MV, et al.

    Neurosurgical review 2024; (47(1)):664 doi:10.1007/s10143-024-02878-z.

    PMID: 39312085
  7. 7

    Valproate-induced hyperammonemic encephalopathy: the role of clinical pharmacists in medication safety-a case report.

    Chen W, Wang D, Fu W, et al.

    Journal of medical case reports 2025; (19(1)):302 doi:10.1186/s13256-025-05294-z.

    PMID: 40598597
  8. 8

    Long-term hemodynamic changes in cerebral proliferative angiopathy presenting with intracranial hemorrhage: illustrative case.

    Saito T, Harada K, Kajihara M, et al.

    Journal of neurosurgery. Case lessons 2023; (5(16)).

    PMID: 37070681
  9. 9

    De novo ruptured intracranial aneurysm associated with cerebral proliferative angiopathy: illustrative case.

    Suetsugu H, Okawa S, Ishibashi T, et al.

    Journal of neurosurgery. Case lessons 2026; (12(7)).

    PMID: 42607334
  10. 10

    Cerebral revascularization in cerebral proliferative angiopathy: a systematic review.

    Somji M, McEachern J, Silvaggio J

    Neurosurgical focus 2019; (46(2)):E11.

    PMID: 30717067
  11. 11

    Infratentorial hemorrhagic cerebral proliferative angiopathy: A rare presentation of a rare disease.

    Kumar S, Sharma M, Srivastava T, Sinha VD

    Asian journal of neurosurgery 2015; (10(3)):240-2 doi:10.4103/1793-5482.161185.

    PMID: 26396618
  12. 12

    Systematic review of pediatric cerebral proliferative angiopathy.

    Yamaki VN, Alwis A, Chowdhury SS, et al.

    Journal of neurosurgery. Pediatrics 2026; 1-13 doi:10.3171/2026.4.PEDS25435.

    PMID: 42854234
  13. 13

    Cerebral proliferative angiopathy: Clinical, angiographic features and literature review.

    Liu P, Lv X, Lv M, Li Y

    Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences 2016; (22(1)):101-7 doi:10.1177/1591019915609784.

    PMID: 26472638
  14. 14

    A Proposed Algorithm for Managing Cerebral Proliferative Angiopathy.

    Chen YN, Lee CW, Xiao F, et al.

    World neurosurgery 2022; (167()):e360-e369 doi:10.1016/j.wneu.2022.08.009.

    PMID: 35961587
  15. 15

    Embolization of ruptured arteriovenous malformations in the cerebellopontine angle cistern.

    Endo H, Osawa SI, Matsumoto Y, et al.

    Neurosurgical review 2018; (41(1)):173-182 doi:10.1007/s10143-017-0832-1.

    PMID: 28220368
  16. 16

    Stereotactic radiosurgery for deep intracranial arteriovenous malformations, part 1: Brainstem arteriovenous malformations.

    Cohen-Inbar O, Ding D, Chen CJ, Sheehan JP

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2016; (24()):30-6.

    PMID: 26740034
  17. 17

    Cerebral proliferative angiopathy depicted by four-dimensional computed tomographic angiography: A case report.

    Ito S, Kanagaki M, Yoshimoto N, et al.

    Radiology case reports 2022; (17(7)):2332-2336 doi:10.1016/j.radcr.2022.03.104.

    PMID: 35570862

This page is for informational purposes only and does not constitute medical advice. A specialized neurovascular team should review your imaging, symptoms, and treatment options with you.

Guide contents Cerebral proliferative angiopathy
Research & Literature
04 Treating CPA 06 Living with CPA